Prevalence of diabetes and impaired fasting glucose among 769 792 rural Chinese adults

Diabetes Research and Clinical Practice

Volumn 84, Issue 3, 2009, Pages 273-278

  Tian, Huiguang ^a   Song, Guide ^b   Xie, Hongxiang ^a   Zhang, Hong ^a   Tuomilehto, Jaakko ^c,d   Hu, Gang ^c,d,e  

^a Tianjin Public Health Bureau   (China)

^b TIANJIN CENTERS FOR DISEASE CONTROL AND PREVENTION   (China)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

China; Diabetes; Prevalence; Rural

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHINESE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; HUMAN TISSUE; IMPAIRED FASTING GLUCOSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; RURAL AREA; SCREENING; URBAN AREA; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BLOOD PRESSURE; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RURAL POPULATION; SMOKING;

EID: 67349157142     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.03.015     Document Type: Article

References (41)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Qi L., Hu F.B., and Hu G. Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Curr. Mol. Med. 8 (2008) 519-532
3. Hu G., Lindstrom J., Jousilahti P., Peltonen M., Sjoberg L., Kaaja R., et al. The increasing prevalence of Metabolic Syndrome among Finnish men and women over a decade. J. Clin. Endocrinol. Metab. 93 (2008) 832-836
4. Popkin B.M., Paeratakul S., Zhai F., and Ge K. Dietary and environmental correlates of obesity in a population study in China. Obes. Res. 3 Suppl. 2 (1995) 135s-143s
5. National Diabetes Research Group. Diabetes mellitus survey of 300,000 subjects in 14 provinces and cities of China. Chin. J. Intern. Med. 20 (1981) 678-681
6. Pan X.R., Yang W.Y., Li G.W., and Liu J. Prevalence of diabetes and its risk factors in China, 1994. Diabetes Care 20 (1997) 1664-1669
7. Ministry of Public Health. Nutrition and Health Status Among Chinese: Result from the Fourth China Nutrition and Health Survey (2004), Ministry of Public Health edn., Beijing
8. Wang Y., Mi J., Shan X.Y., Wang Q.J., and Ge K.Y. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int. J. Obes. (Lond.) 31 (2007) 177-188
9. Hu G., Pekkarinen H., Hanninen O., Tian H., and Jin R. Comparison of dietary and non-dietary risk factors in overweight and normal-weight Chinese adults. Br. J. Nutr. 88 (2002) 91-97
10. Shi Z., Hu X., Yuan B., Hu G., Pan X., Dai Y., et al. Vegetable-rich food pattern is related to obesity in China. Int. J. Obes. (Lond). 32 (2008) 975-984
11. Tian H., Xie H., Song G., Zhang H., and Hu G. Prevalence of overweight and obesity among 2.6 million rural Chinese adults. Prev. Med. 48 (2009) 59-63
12. Who Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus (1999), World Health Organisation, Geneva
13. National Bureau of Statistics of China, China Statistical Yearbook 2001: The Fifth National Population Census Data, Beijing, 2001 (in Chinese).
14. Wu Y. Overweight and obesity in China. BMJ 333 (2006) 362-363
15. Hu G., Lindstrom J., Valle T.T., Eriksson J.G., Jousilahti P., Silventoinen K., et al. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch. Intern. Med. 164 (2004) 892-896
16. Hartemink N., Boshuizen H.C., Nagelkerke N.J., Jacobs M.A., and Van Houwelingen H.C. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am. J. Epidemiol. 163 (2006) 1042-1052
17. Hu G., Jousilahti P., Peltonen M., Bidel S., and Tuomilehto J. Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. Int. J. Obes. (Lond.) 30 (2006) 1742-1749
18. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 48 (1999) 937-942
19. Hu G., Jousilahti P., Qiao Q., Katoh S., and Tuomilehto J. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 48 (2005) 856-861
20. Hu G., Jousilahti P., Sarti C., Antikainen R., and Tuomilehto J. The effect of diabetes and stroke at baseline and during follow-up on stroke mortality. Diabetologia 49 (2006) 2309-2316
21. Hu G., Jousilahti P., Qiao Q., Peltonen M., Katoh S., and Tuomilehto J. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J. Am. Coll. Cardiol. 45 (2005) 1413-1418
22. Hu G., Sarti C., Jousilahti P., Peltonen M., Qiao Q., Antikainen R., et al. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 36 (2005) 2538-2543
23. Hu G., Jousilahti P., and Tuomilehto J. Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease. Eur. Heart J. 28 (2007) 3059-3066
24. Hu G., Jousilahti P., Bidel S., Antikainen R., and Tuomilehto J. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30 (2007) 842-847
25. Khalangot M., Tronko M., Kravchenko V., Kulchinska J., and Hu G. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes. Diabetes Res. Clin. Pract. 82 (2008) 139-147
26. Khalangot M., Hu G., Tronko M., Kravchenko V., and Guryanov V. Gender risk of nonfatal stroke in type 2 diabetic patients differs depending on the type of treatment. J. Womens Health (Larchmt) 18 (2009) 97-103
27. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22 (1999) 920-924
28. Hu G., and Decode Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 46 (2003) 608-617
29. Wang J.J., Li H.B., Kinnunen L., Hu G., Jarvinen T.M., Miettinen M.E., et al. How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population?. Atherosclerosis 192 (2007) 161-168
30. Wang J.J., Hu G., Miettinen M.E., and Tuomilehto J. The metabolic syndrome and incident diabetes: assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial glucose. Horm. Metab. Res. 36 (2004) 708-715
31. Wang J.J., Yuan S.Y., Zhu L.X., Fu H.J., Li H.B., Hu G., et al. Effects of impaired fasting glucose and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with high post-prandial glucose. Diabetes Res. Clin. Pract. 66 (2004) 183-191
32. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 (2001) 1343-1350
33. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 (2002) 393-403
34. Bassuk S.S., and Manson J.E. Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease. J. Appl. Physiol. 99 (2005) 1193-1204
35. Eriksson K.F., and Lindgarde F. No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise. Diabetologia 41 (1998) 1010-1016
36. Li G., Zhang P., Wang J., Gregg E.W., Yang W., Gong Q., et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371 (2008) 1783-1789
37. Hu G., Lakka T.A., Kilpelainen T.O., and Tuomilehto J. Epidemiological studies of exercise in diabetes prevention. Appl. Physiol. Nutr. Metab. 32 (2007) 583-595
38. Nakagami T. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47 (2004) 385-394
39. Nakagami T., Qiao Q., Tuomilehto J., Balkau B., Tajima N., Hu G., et al. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur. J. Cardiovasc. Prev. Rehabil. 13 (2006) 555-561
40. Carstensen B., Lindstrom J., Sundvall J., Borch-Johnsen K., and Tuomilehto J. Measurement of blood glucose: comparison between different types of specimens. Ann. Clin. Biochem. 45 (2008) 140-148
41. Qiao Q., Hu G., Tuomilehto J., Borch-Johnsen K., Ramachandran A., Mohan V., et al. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 26 (2003) 1770-1780